FDA applicant
Fluoptics
FDA records 4 decisions for Fluoptics (Grenoble Cedex 9, FR) from 2014 to 2023: 3 510(k) clearances and 1 De Novo grant. Most are in product codes QDG (Parathyroid Autofluorescence Imaging Device) and OWN (Confocal Optical Imaging). Its devices cite 1 predicate, 1 of them its own earlier devices. No recall is linked to its devices.
FDA’s records also spell it “Fluoptics Sas”.
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly
How often FDA has decided Fluoptics’s devices, and how often a recall has named them.
FDA decisions per year
1in 2023
2026 so far, outlined.
Recalls per year
No recall linked to its devices since 2014.
Planning a device like Fluoptics’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.
See the 510(k) ReportOther applicant names beginning “Fluoptics”
FDA records each applicant name separately; these may or may not be the same firm.